Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01804452 · ClinicalTrials.gov registry record
4 Repeat Tauopathy Neuroimaging Initiative
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 110
- Enrollment target
NCT01804452: Completed study, sponsored by University of California, San Francisco.
NCT01804452 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 110 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01804452 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 110 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate several different tests, including brain imaging, eye movement testing, body fluid samples, measurements of memory and other thinking abilities, and measures of functional independence in the hope that this information can be used to guide diagnosis and treatment of PSP and CBD in the future. Recent advances in our understanding of the biological causes of these diseases offer hope for new treatments. As such treatments are developed, sensitive and specific biological measurements (biomarkers) will be needed to provide precise and direct measures of the state of the brain, which will improve the statistical power of clinical trials. Brain imaging with Magnetic Resonance Imaging (MRI) has previously been used to measure disease-related changes in the brain. The goal of this study is to identify the best methods of analysis (including eye movements, imaging, and behavioral measures) for tracking PSP and CBD over time. In addition, certain biomarkers in the blood and cerebrospinal fluid might also be useful for following these diseases over time. This study will examine the value of blood and CSF biomarkers relative to brain imaging and functional measures.
Primary Outcome
Change from baseline
Interventions
- OTHER Observational Study
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2011-01-10 |
| Est. Completion | 2016-03-01 |
What the finished NCT01804452 record still lists
NCT01804452 is an observational study that tracks outcomes without assigning an intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Observational Study is the first listed.
NCT01804452 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01804452 about?
NCT01804452 is a clinical study titled "4 Repeat Tauopathy Neuroimaging Initiative". The purpose of this study is to evaluate several different tests, including brain imaging, eye movement testing, body fluid samples, measurements of memory and other thinking abilities, and measures of functional independence in the hope that this information can be used to guide diagnosis and treat...
What is the current status of trial NCT01804452?
This trial is currently completed. The enrollment target is 110 participants. The study started on 2011-01-10. Estimated completion is 2016-03-01.
What interventions are being tested in trial NCT01804452?
The interventions under investigation include: Observational Study (OTHER).
Who is sponsoring clinical trial NCT01804452?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01530373 · 110 participants · Phase 2
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- NCT02379377 · 110 participants · Phase 1
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- NCT02411773 · 110 participants · Phase 1
Sympatholysis in Chronic Kidney Disease
- NCT03190941 · 110 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI